UMB Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
1,057
+161
| +18% | +$20.2K | ﹤0.01% | 725 |
|
|
2025
Q1 | $99.1K | Buy |
896
+441
| +97% | +$48.8K | ﹤0.01% | 764 |
|
|
2024
Q4 | $62.1K | Buy |
455
+309
| +212% | +$42.2K | ﹤0.01% | 829 |
|
|
2024
Q3 | $16.8K | Buy |
146
+84
| +135% | +$9.68K | ﹤0.01% | 1296 |
|
|
2024
Q2 | $8.54K | Buy |
62
+38
| +158% | +$5.23K | ﹤0.01% | 1299 |
|
|
2024
Q1 | $3.31K | Buy |
+24
| New | +$3.31K | ﹤0.01% | 1426 |
|
|
2023
Q4 | – | Sell |
-2
| Closed | -$225 | – | 1698 |
|
|
2023
Q3 | $225 | Hold |
2
| – | – | ﹤0.01% | 1665 |
|
|
2023
Q2 | $189 | Buy |
+2
| New | +$189 | ﹤0.01% | 1655 |
|
|
2022
Q1 | – | Sell |
-36
| Closed | -$3K | – | 2040 |
|
|
2021
Q4 | $3K | Buy |
+36
| New | +$3K | ﹤0.01% | 1750 |
|